Market Size of Lateral Flow Assay Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 10.46 Billion |
Market Size (2029) | USD 14.79 Billion |
CAGR (2024 - 2029) | 7.18 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Lateral Flow Assay Market Analysis
The Lateral Flow Assay Market size is estimated at USD 10.46 billion in 2024, and is expected to reach USD 14.79 billion by 2029, growing at a CAGR of 7.18% during the forecast period (2024-2029).
The factors driving the growth of the market are increased demand for point-of-care testing (POC) with technological advancements, the rise in the adoption of home-based devices, and the global incidence of infectious diseases. For instance, according to the study article published in Asian Biomedicine in December 2023, Lateral Flow Assays (LFAs) are considered ideal POC devices. Consumers and regulatory authorities prefer them the most for disease diagnostics globally. LFAs have a simple designated structure, making them portable and equipment-free. LFAs, with their comparatively low manufacturing costs, are priced affordably in the market. Thus, studies like this emphasize the significant benefits of point-of-care testing in diagnosing diseases, which is expected to contribute to Lateral Flow Assays Market growth during the forecast period.
Also, the growing prevalence of infectious diseases such as HIV, Tuberculosis, and Acute Hepatitis and increasing demand for testing kits like Rapid Diagnostic Kits will boost the market during the forecast period. For instance, according to the United Nations Programme on HIV/AIDS Global AIDS Update 2024, globally, 39.9 million people lived with HIV at the end of 2023, an increase of 2.3% compared to 2022. Thus, with the high prevalence of HIV, the demand for its testing increases, thereby driving the Rapid Diagnostics Market growth during the forecast period.
Additionally, the new research and studies and technological developments in the Lateral Flow Assay Market are expected to drive the growth of the market. For instance, an article published in Multidisciplinary Digital Publishing Institute in October 2022 highlighted advancements in Lateral Flow Immunoassays. The highlighted developments are crucial for detecting adulteration and toxic substances in food and drug samples by integrating robust sensors boasting ultra-high reproducibility. Thus, such technological developments are increasing the adoption of LFAs, thereby driving the growth of the market.
Consequently, driven by rising demand for point-of-care testing, technological advancements, and significant disease burden, the market is poised for good growth during the forecast period, according to current Lateral Market Trends. However, stringent and tedious regulatory frameworks, leading to delays in the approval of products, and the risk of false results and reluctance toward these products among people in emerging nations are expected to hinder the growth of the market during the forecast period.
Lateral Flow Assay Industry Segmentation
As per the scope of the report, lateral flow assays, also referred to as lateral flow immunochromatographic assays, are cellulose-based devices used to detect the presence of a target analyte in the sample without the need for specialized and costly equipment and highly skilled healthcare professionals for their operation.
The lateral flow assay market is segmented by application, technique, product, end user, and geography. By application, the market is segmented into clinical testing, drug abuse testing, and other applications. The clinical testing segment includes pregnancy testing, influenza testing, tuberculosis, D-dimer testing, and other clinical testing. By technique, the market is segmented into sandwich assay, competitive assay, and multiplex assay. By product, the market is segmented into lateral flow readers and kits and reagents. The lateral flow readers include digital/mobile readers and benchtop readers. By end user, the market is segmented into home care, hospitals and clinics, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for all the above segments.
By Application | |||||||
| |||||||
Drug Abuse Testing | |||||||
Other Applications |
By Technique | |
Sandwich Assay | |
Competitive Assay | |
Multiplex Assay |
By Product | ||||
| ||||
Kits and Reagents |
By End User | |
Home Care | |
Hospitals and Clinics | |
Other End Users |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Lateral Flow Assay Market Size Summary
The lateral flow assay market is poised for significant growth over the forecast period, driven by the increasing global prevalence of infectious diseases, HIV, and cancer, which necessitate effective diagnostic methods. The COVID-19 pandemic has notably accelerated the adoption of lateral flow tests due to their portability, ease of use, and rapid results, making them ideal for mass screening programs, especially in regions with limited laboratory infrastructure. Technological advancements in lateral flow assays, such as novel signal enhancement techniques and improved quantification systems, have further bolstered market expansion. The market is also witnessing increased government participation in controlling infectious disease outbreaks and raising awareness about diagnosis and prevention, which is expected to contribute to its growth.
North America is anticipated to dominate the lateral flow assay market, supported by a high incidence of infectious and chronic diseases and a robust healthcare infrastructure. The United States, in particular, is expected to hold a significant market share due to its large patient pool and increased disposable income. The region's market growth is further fueled by the rapid spread of infectious diseases and the implementation of mass screening programs during the pandemic. The market is moderately competitive, with major players like Abbott Laboratories, Hologic Inc., and Quidel Corporation expanding their presence through strategic mergers, acquisitions, and the introduction of new diagnostic products. These developments are expected to sustain the market's upward trajectory in the coming years.
Lateral Flow Assay Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increased Demand for Point-of-Care Testing with Technological Advancements
-
1.2.2 Rise in Adoption of Home-based Devices, along with Global Incidence of Infectious Diseases
-
-
1.3 Market Restraints
-
1.3.1 Stringent and Tedious Regulatory Framework that Delays the Approval of Products
-
1.3.2 Risk of False Results and Reluctance Toward these Products among the People in Emerging Nations
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD)
-
2.1 By Application
-
2.1.1 Clinical Testing
-
2.1.1.1 Pregnancy Testing
-
2.1.1.2 Influenza Testing
-
2.1.1.3 Tuberculosis
-
2.1.1.4 D-dimer Testing
-
2.1.1.5 Other Clinical Testing
-
-
2.1.2 Drug Abuse Testing
-
2.1.3 Other Applications
-
-
2.2 By Technique
-
2.2.1 Sandwich Assay
-
2.2.2 Competitive Assay
-
2.2.3 Multiplex Assay
-
-
2.3 By Product
-
2.3.1 Lateral Flow Readers
-
2.3.1.1 Digital/Mobile Readers
-
2.3.1.2 Benchtop Readers
-
-
2.3.2 Kits and Reagents
-
-
2.4 By End User
-
2.4.1 Home Care
-
2.4.2 Hospitals and Clinics
-
2.4.3 Other End Users
-
-
2.5 Geography
-
2.5.1 North America
-
2.5.1.1 United States
-
2.5.1.2 Canada
-
2.5.1.3 Mexico
-
-
2.5.2 Europe
-
2.5.2.1 Germany
-
2.5.2.2 United Kingdom
-
2.5.2.3 France
-
2.5.2.4 Italy
-
2.5.2.5 Spain
-
2.5.2.6 Rest of Europe
-
-
2.5.3 Asia-Pacific
-
2.5.3.1 China
-
2.5.3.2 Japan
-
2.5.3.3 India
-
2.5.3.4 Australia
-
2.5.3.5 South Korea
-
2.5.3.6 Rest of Asia-Pacific
-
-
2.5.4 Middle East and Africa
-
2.5.4.1 GCC
-
2.5.4.2 South Africa
-
2.5.4.3 Rest of Middle East and Africa
-
-
2.5.5 South America
-
2.5.5.1 Brazil
-
2.5.5.2 Argentina
-
2.5.5.3 Rest of South America
-
-
-
Lateral Flow Assay Market Size FAQs
How big is the Lateral Flow Assay Market?
The Lateral Flow Assay Market size is expected to reach USD 10.46 billion in 2024 and grow at a CAGR of 7.18% to reach USD 14.79 billion by 2029.
What is the current Lateral Flow Assay Market size?
In 2024, the Lateral Flow Assay Market size is expected to reach USD 10.46 billion.